col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

105 Results       Page 1

Elsevier: International Journal of Drug Policy
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―26 Alcohol policy changes during the first three-months of the COVID-19 pandemic: Development and application of a classification scheme Sebastián Peña, Claire Wilkinson, Giovanni Aresi, Liz Barrett, Sadie Boniface, Niamh Fitzgerald, et al. (+4)
2 [GO] 2024―Mar―23 Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic in Ontario, Canada: A population-based analysis Shaleesa Ledlie, Mina Tadrous, Ahmed M. Bayoumi, Daniel McCormack, Clare Cheng, Jes Besharah, et al. (+2)
3 [GO] 2024―Mar―13 An ecological study of the correlation between COVID-19 support payments and overdose events in British Columbia, Canada Lindsey Richardson, Cameron Geddes, Heather Palis, Jane Buxton, Amanda Slaunwhite
4 [GO] 2024―Mar―05 Volatile drug use and overdose during the first year of the COVID-19 pandemic in the United States Kristin E. Schneider, Emily M. Martin, Sean T. Allen, Miles Morris, Katherine Haney, Brendan Saloner, Susan G. Sherman
5 [GO] 2024―Jan―05 Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19 Victor Roy, Michele Buonora, Caty Simon, Bridget Dooling, Paul Joudrey
6 [GO] 2023―Nov―25 Understanding problematic substance use among first responders during the COVID-19 pandemic: A survey of law enforcement, fire, and EMS workers in the United States Kaila Witkowski, Ryan J. Lofaro, Andrea M. Headley, Santina Contreras, Christa L. Remington, N.Emel Ganapati
7 [GO] 2023―Oct―27 Restrictive measures and substance use reporting: New evidence from the COVID-19 pandemic Andrea Rebucini, Federica Origo, Francesca Schionato, Francesco Saverio Romolo
8 [GO] 2023―Oct―03 Negative changes in illicit drug supply during COVID-19: Associations with use of overdose prevention and health services among women sex workers who use drugs (2020-2021) Sarah Moreheart, Kate Shannon, Andrea Krüsi, Jennifer McDermid, Emma Ettinger, Melissa Braschel, Shira Miriam Goldenberg
9 [GO] 2023―Aug―11 Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis Mohammad Karamouzian, Bijan Rafat, Gillian Kolla, Karen Urbanoski, Kate Atkinson, Geoff Bardwell, et al. (+21)
10 [GO] 2023―Jul―18 Residence in urban or rural counties in relation to opioid overdose mortality among Kentucky hospitalizations before and during the COVID-19 pandemic Lyndsey K. Blair, Jeffrey Howard, Nicholas C. Peiper, Bert B. Little, Kira C. Taylor, Richard Baumgartner, et al. (+2)
11 [GO] 2023―Jun―08 General hospital admissions in young and middle-aged people who use psychoactive substances: impact of Covid-19 lockdowns J Perino, H Ramaroson, N Ong, J Bezin, V Gilleron, A Daveluy, M Tournier
12 [GO] 2023―May―22 A new outbreak of HIV infection among people who inject drugs during the COVID-19 pandemic in Greece Vana Sypsa, Sotirios Roussos, Efrossini Tsirogianni, Chrissa Tsiara, Dimitra Paraskeva, Theofilos Chrysanthidis, et al. (+6)
13 [GO] 2023―May―22 Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: an interrupted time series analysis M. Eugenia SOCIAS, Jin Cheol CHOI, Nadia FAIRBAIRN, Cheyenne JOHNSON, Dean WILSON, Kora DEBECK, et al. (+2)
14 [GO] 2023―May―15 The impacts of COVID-19 on structural inequities faced by people living with HIV who inject drugs: A qualitative study in St. Petersburg, Russia Jennifer J. Carroll, Sarah L. Rossi, Marina V. Vetrova, Elena Blokhina, Yuliia Sereda, Dmitry Lioznov, et al. (+3)
15 [GO] 2023―May―08 Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review Alison Adams, Sarin Blawatt, Scott MacDonald, Rhys Finnick, Julie Lajeunesse, Scott Harrison, et al. (+3)
16 [GO] 2023―May―08 What's in Stock? Drug drought anticipation during COVID-19 among people who use drugs and service providers Maj Nygaard-Christensen, Thomas Friis Søgaard
17 [GO] 2023―May―05 Impact of COVID-19 on Poisoning-Related Mortality in Iran: An Interrupted Time Series Study Amir Hossein Behnoush, Elham Bazmi, Mehdi Forouzesh, Steven A Koehler, Seyed Jalil Monabati, Behnam Behnoush
18 [GO] 2023―Apr―26 Public Transport Access to Drug Treatment Before and During COVID-19: Implications for the Opioid Epidemic Yücel Shiv Gazi, Christopher D. Higgins, Gupta Kumar, Matthew Palm
19 [GO] 2023―Apr―07 Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): a modeling study Charlotte Lanièce Delaunay, Marina B. Klein, Arnaud Godin, Joseph Cox, Nadine Kronfli, Bertrand Lebouché, et al. (+2)
20 [GO] 2023―Apr―03 Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies Karen Giang, Reith Charlesworth, Madison Thulien, Alanna Mulholland, Brittany Barker, Rupinder Brar, et al. (+2)
21 [GO] 2023―Mar―06 “You'll come in and dose even in a global pandemic”: a qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic Anna Conway, Carla Treloar, Sione Crawford, Louisa Degenhardt, Gregory J Dore, Michael Farrell, et al. (+3)
22 [GO] 2023―Mar―05 Changes in hazardous drinking pre, during and post 70-day alcohol sales ban during COVID-19 pandemic in Botswana J. Maphisa Maphisa, Thokozani B.H. Ndlovu
23 [GO] 2023―Feb―16 Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions Olivia Price, Nicola Man, Rachel Sutherland, Raimondo Bruno, Paul Dietze, Caroline Salom, et al. (+4)
24 [GO] 2022―Nov―22 Increased Solitary Drug Use during COVID-19: An Unintended Consequence of Social Distancing Kristin E. Schneider, Sean T. Allen, Saba Rouhani, Miles Morris, Katherine Haney, Brendan Saloner, Susan G. Sherman
25 [GO] 2022―Oct―20 How Covid-19 restrictions affected young people's well-being and drinking practices? Analyzing interview material with a socio-material approach Jukka Törrönen, Josefin Månsson, Eva Samuelsson, Filip Roumeliotis, Johan Svensson, Ludwig Kraus, Robin Room
26 [GO] 2022―Oct―17 A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic Heather Bradley, Chelsea Austin, Sean T. Allen, Alice Asher, Tyler S. Bartholomew, Amy Board, et al. (+15)
27 [GO] 2022―Oct―17 Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study Camille Zolopa, Thomas D. Brothers, Pascale Leclerc, Jean-François Mary, Carole Morissette, Julie Bruneau, et al. (+3)
28 [GO] 2022―Oct―04 Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England D Aldabergenov, L Reynolds, J Scott, MJ Kelleher, J Strang, CS Copeland, NJ Kalk
29 [GO] 2022―Sep―21 “Maintaining HIV and HCV prevention and care for people who inject drugs despite COVID-19 in Hai Phong, Vietnam” Hoang Thi Giang, Nguyen Quang Duc, Jean-Pierre Molès, Vu Hai Vinh, Nicolas Nagot, Nham Thi Tuyet Thanh, et al. (+13)
30 [GO] 2022―Aug―23 Mortality by Cause of Death during Year 1 of the COVID-19 Pandemic in a Cohort of Older Adults from Baltimore Maryland who Have Injected Drugs Kenneth A. Feder, Jing Sun, Jacqueline E. Rudolph, Javier Cepeda, Jacquie Astemborski, Pieter A. Baker, et al. (+4)
31 [GO] 2022―Aug―15 Impact of COVID-19 on the Characteristics of Opioid Overdose Deaths in Arkansas Mandana Rezaeiahari, Brian J. Fairman
32 [GO] 2022―Aug―10 Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives Elizabeth J. Austin, Maria A. Corcorran, Elsa S. Briggs, Madeline C. Frost, Czarina N. Behrends, Alexa M. Juarez, et al. (+10)
33 [GO] 2022―Aug―08 COVID-19 and the opportunity for gender-responsive virtual and remote substance use treatment and harm reduction services Melissa Perri, Rose A. Schmidt, Adrian Guta, Natalie Kaminski, Katherine Rudzinski, Carol Strike
34 [GO] 2022―Aug―03 SUBSTANCE USE AND HOMELESSNESS: A LONGITUDINAL INTERVIEW STUDY CONDUCTED DURING COVID-19 WITH IMPLICATIONS FOR POLICY AND PRACTICE Joanne Neale, Stephen Parkin, Laura Hermann, Nicola Metrebian, Emmert Roberts, Deborah Robson, John Strang
35 [GO] 2022―Jul―01 A rapid assessment of take-home naloxone provision during COVID-19 in Europe Rebecca McDonald, Desiree Eide, Katri Abel-Ollo, Lee Barnsdale, Ben Carter, Thomas Clausen, et al. (+18)
36 [GO] 2022―Jun―16 COVID-19 economic impact payments and opioid overdose deaths: a response Jon E. Sprague, Arthur B. Yeh, Qizhen Lan, Jamie Vieson, Maggie McCorkle
37 [GO] 2022―Jun―16 Consensus recommendations for opioid agonist treatment following the introduction of emergency clinical guidelines in Ireland during the COVID-19 pandemic: a national Delphi study Louise Durand, Eamon Keenan, Fiona Boland, Norma Harnedy, Íde Delargy, Mike Scully, et al. (+8)
38 [GO] 2022―Jun―06 “COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada Stephanie Glegg, Karen McCrae, Gillian Kolla, Natasha Touesnard, Jeffrey Turnbull, Thomas D. Brothers, et al. (+8)
39 [GO] 2022―May―27 A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives Tom May, Jo Dawes, Daisy Fancourt, Alexandra Burton
40 [GO] 2022―May―14 Impact of COVID-19 on substance use disorder treatment services in Kenya: Qualitative findings from healthcare providers Abbe Muller, Matthew J Akiyama, Lindsey Riback, Mercy Nyakowa, Helgar Musyoki, Peter Cherutich, Ann Kurth
41 [GO] 2022―May―04 Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency Marion Selfridge, Kiffer Card, Taylor Kandler, Erin Flanagan, Emily Lerhe, Ash Heaslip, et al. (+5)
42 [GO] 2022―Apr―13 Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions Zachary Bouck, Ayden I. Scheim, Tara Gomes, Vicki Ling, Alexander Caudarella, Dan Werb
43 [GO] 2022―Apr―04 Temporal monitoring of stimulants during the COVID-19 pandemic in Belgium through the analysis of influent wastewater Tim Boogaerts, Maarten Quireyns, Maarten De prins, Bram Pussig, Hans De Loof, Catharina Matheï, et al. (+5)
44 [GO] 2022―Mar―07 Israeli News media coverage of COVID-19 and use of cannabis and tobacco: A case study of inconsistent risk communication Sharon R. Sznitman, Nehama Lewis
45 [GO] 2022―Mar―01 Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: a population-based time-series analysis Sophie A. Kitchen, Tonya J. Campbell, Siyu Men, Nikki Bozinoff, Mina Tadrous, Tony Antoniou, et al. (+4)
46 [GO] 2022―Feb―17 A rapid ethnographic study of risk negotiation during the COVID-19 pandemic among unstably housed people who use drugs in Rhode Island Alexandra B. Collins, Sarah Edwards, Ryan McNeil, Jacqueline Goldman, Benjamin D. Hallowell, Rachel P. Scagos, Brandon D.L. Marshall
47 [GO] 2022―Jan―31 COVID-19 economic impact payments and opioid overdose deaths Jon E. Sprague, Arthur B. Yeh, Qizhen Lan, Jamie Vieson, Maggie McCorkle
48 [GO] 2022―Jan―31 Examining Reactions to Smoking and COVID-19 Risk Messages: An Experimental Study with People Who Smoke Zachary B. Massey, Hue T. Duong, Victoria M. Churchill, Lucy Popova
49 [GO] 2022―Jan―25 Changes in retrospectively recalled alcohol use pre, during and post alcohol sales prohibition during COVID pandemic in Botswana J. Maphisa Maphisa, Kefentse Mosarwane
50 [GO] 2022―Jan―20 Methadone Exposures Reported to Poison Control Centers in the United States Following the COVID-19-Related Loosening of Federal Methadone Regulations Christopher Welsh, Suzanne Doyon, Katherine Hart
51 [GO] 2022―Jan―05 No party, no drugs? Use of stimulants, dissociative drugs, and GHB/GBL during the early COVID-19 pandemic1 Antonia Bendau, Leonard Viohl, Moritz Bruno Petzold, Jonas Helbig, Simon Reiche, Roman Marek, et al. (+10)
52 [GO] 2021―Dec―23 Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients’ and prescribers’ experiences with changes in unsupervised dosing Kim Corace, Kelly Suschinsky, Jennifer Wyman, Pamela Leece, Sue Cragg, Sarah Konefal, et al. (+4)
53 [GO] 2021―Dec―20 Treatment of Hepatitis C Virus among People Who Inject Drugs at a Syringe Service Program During the COVID-19 Response: the Potential Role of Telehealth, Medications for Opioid Use DIsorder and Minimal Demands on Patients Anishaa Sivakumar, Lynn Madden, Elizabeth DiDomizio, Anthony Eller, Merceditas Villanueva, Frederick L. Altice
55 [GO] 2021―Dec―08 Impacts of changes in alcohol consumption patterns during the first 2020 COVID-19 restrictions for people with and without mental health and neurodevelopmental conditions: A cross sectional study in 13 countries Emma L. Davies, Cheneal Puljevic, Gail Gilchrist, Laura Potts, Ahnjili Zhuparris, Larissa J. Maier, et al. (+3)
56 [GO] 2021―Dec―01 The COVID-19 Pandemic and the Health of People Who Use Illicit Opioids in New York City, the First 12 Months Alex S. Bennett, Tarlie Townsend, Luther Elliott
57 [GO] 2021―Nov―26 Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic - is an update of legal restrictions warranted? Maximilian Meyer, Johannes Strasser, Patrick Köck, Marc Walter, Marc Vogel, Kenneth M. Dürsteler
58 [GO] 2021―Nov―19 Experiences with Substance Use Disorder Treatment During the COVID-19 Pandemic: Findings from a Multistate Survey Brendan Saloner, Noa Krawczyk, Keisha Solomon, Sean T. Allen, Miles Morris, Katherine Haney, Susan G. Sherman
59 [GO] 2021―Oct―29 Trends in cannabis use among U.S. adults amid the COVID-19 pandemic Savannah G. Brenneke, Courtney D. Nordeck, Kira E. Riehm, Ian Schmid, Kayla N. Tormohlen, Emily J. Smail, et al. (+4)
60 [GO] 2021―Sep―29 The success rate of online illicit drug transactions during a global pandemic Andréanne Bergeron, David Décary-Hétu, Luca Giommoni, Marie-Pier Villeneuve-Dubuc
61 [GO] 2021―Sep―20 Twitter Discourse on Nicotine as Potential Prophylactic or Therapeutic for COVID-19 Ramakanth Kavuluru, Jiho Noh, Shyanika W. Rose
62 [GO] 2021―Aug―04 Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington Gillian L. Schauer, Julia A. Dilley, Douglas R. Roehler, Thomas J. Sheehy, Jessica R. Filley, Sara Cooley Broschart, et al. (+4)
63 [GO] 2021―Aug―03 Using a “Big Events” framework to understand emergency department use among women experiencing homelessness or housing instability in San Francisco during the COVID-19 pandemic Elise D. Riley, Maria C. Raven, Samantha E. Dilworth, Carl Braun, Elizabeth Imbert, Kelly M. Doran
64 [GO] 2021―Jul―20 Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): a qualitative study of experiences of COVID-19 among people who inject drugs Joanna M. Kesten, Adam Holland, Myles-Jay Linton, Hannah Family, Jenny Scott, Jeremy Horwood, et al. (+6)
65 [GO] 2021―Jul―20 Changes in Characteristics of Drug Overdose Death Trends during the COVID-19 Pandemic Catherine DiGennaro, Gian-Gabriel P. Garcia, Erin J. Stringfellow, Sarah Wakeman, Mohammad S. Jalali
66 [GO] 2021―Jun―14 “I'm pretty sure it's either food poisoning or Covid-19”: Lived experience versus medical knowledge in diagnosing substance use problems David Frank
67 [GO] 2021―Jun―08 Lessons Learned Recruiting A Diverse Sample of Rural Study Participants During the COVID-19 Pandemic Nam Hyo Kim, NeCall Wilson, Trish Mashburn, Lauren Reist, Salisa C. Westrick, Kevin Look, et al. (+2)
68 [GO] 2021―May―14 Political Partisanship and Stigma Against People Who Use Drugs in Opinions About Allocating COVID-19 Prevention Resources to Vulnerable Populations Kristin E. Schneider, Deborah Wilson, Lauren Dayton, Erin M. Anderson Goodell, Carl A. Latkin
69 [GO] 2021―Apr―20 Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada Farihah Ali, Cayley Russell, Frishta Nafeh, Jürgen Rehm, Sean LeBlanc, Tara Elton-Marshall
70 [GO] 2021―Mar―20 Pathways between COVID-19 Public Health Responses and Increasing Overdose Risks: A Rapid Review and Conceptual Framework Tribesty Nguyen, Jane A. Buxton
71 [GO] 2021―Mar―06 A Free Mailed Naloxone Program in Philadelphia amidst the COVID-19 Pandemic Rachel French, Jamie Favaro, Shoshana V. Aronowitz
72 [GO] 2021―Mar―01 Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 “lockdown”: A qualitative study in the United States Daniel P. Giovenco, Torra E. Spillane, Rachel M. Maggi, Esther Y. Lee, Morgan M. Philbin
73 [GO] 2021―Feb―07 “How will I get my next week's script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic Noa Krawczyk, Amanda M. Bunting, David Frank, Joshua Arshonsky, Yuanqi Gu, Samuel R. Friedman, Marie A. Bragg
74 [GO] 2021―Jan―31 Drug-related violence: will COVID-19 drive better data for safer and more secure EU? Teodora Groshkova, Marieke Liem, Andrew Cunningham, Roumen Sedefov, Paul Griffiths
75 [GO] 2021―Jan―20 A rapid review of the impacts of "Big Events" on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19. Camille Zolopa, Stine Hoj, Julie Bruneau, Julie-Soleil Meeson, Nanor Minoyan, Marie-France Raynault, et al. (+2)
76 [GO] 2021―Jan―14 COVID-19 and people who use drugs; Seizing opportunity in times of chaos Ernst WISSE, Naomi Burke-Shyne, Judy Chang, Mat Southwell
77 [GO] 2020―Dec―23 Evidence of Increased Fentanyl Use During the COVID-19 Pandemic Among Opioid Agonist Treatment Patients in Ontario, Canada Kristen A. Morin, Shreedhar Acharya, Joseph K. Eibl, David C. Marsh
78 [GO] 2020―Dec―10 Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19 Michelle Olding, Allison Barker, Ryan McNeil, Jade Boyd
79 [GO] 2020―Nov―24 Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic Kevin F. Boehnke, Jenna McAfee, Joshua M. Ackerman, Daniel J. Kruger
80 [GO] 2020―Nov―20 Possibilities and pitfalls? Moderate drinking and alcohol abstinence at home since the COVID-19 lockdown Emily Nicholls, Dominic Conroy
81 [GO] 2020―Nov―09 COVID-19 and the health of people who use drugs: What is and what could be? Jason Grebely, Magdalena Cerdá, Tim Rhodes
82 [GO] 2020―Nov―07 Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland Austin O'Carroll, Tony Duffin, John Collins
83 [GO] 2020―Oct―27 Supplying synthetic opioids during a pandemic: An early look at North America Bryce Pardo
84 [GO] 2020―Oct―19 Can google trends search inform us about the population response and public health impact of abrupt change in alcohol policy? - a case study from india during the covid-19 pandemic Abhishek Ghosh, Fazl e-Roub, Narayanan C Krishnan, Shinjini Choudhury, Aniruddha Basu
85 [GO] 2020―Oct―16 Understanding Challenges for Recovery Homes During COVID-19 Douglas L. Polcin, Elizabeth Mahoney, Friedner Wittman, Dave Sheridan, Amy A. Mericle
86 [GO] 2020―Aug―26 Virtual raves and happy hours during COVID-19: New drug use contexts for electronic dance music partygoers Joseph J. Palamar, Patricia Acosta
87 [GO] 2020―Aug―17 Coordination, cooperation, and creativity within harm reduction networks in Iran: COVID-19 prevention and control among people who use drugs Maryam Alavi, Amir Moghanibashi-Mansourieh, Seyed Ramin Radfar, Sepideh Alizadeh, Fatemeh Bahramabadian, Sara Esmizade, et al. (+3)
88 [GO] 2020―Aug―15 Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19 Corey S. Davis, Elizabeth A. Samuels
89 [GO] 2020―Aug―11 No “back to normal” after COVID-19 for our failed drug policies Pozo Brandon del, Leo Beletsky
90 [GO] 2020―Jul―31 No magic pocket: Buying and selling on drug cryptomarkets in response to the COVID-19 pandemic and social restrictions Monica J. Barratt, Judith Aldridge
91 [GO] 2020―Jul―30 Preliminary findings of the impact of COVID-19 on drugs crypto markets Andréanne Bergeron, David Décary-Hétu, Luca Giommoni
92 [GO] 2020―Jul―30 Care During COVID-19: Drug Use, Harm Reduction, and Intimacy During a Global Pandemic Allison Schlosser, Shana Harris
93 [GO] 2020―Jul―29 Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs Brendan P. Jacka, Emily Phipps, Brandon D.L. Marshall
94 [GO] 2020―Jul―27 Safer opioid distribution in response to the COVID-19 pandemic Mark Tyndall
95 [GO] 2020―Jul―21 Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19 Alexandra B. Collins, Colleen Daley Ndoye, Diego Arene-Morely, Brandon D.L. Marshall
96 [GO] 2020―Jul―15 The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England Mark Whitfield, Howard Reed, Jane Webster, Vivian Hope
97 [GO] 2020―Jul―06 Isolating the isolated: Implications of COVID-19 quarantine measures on in-patient detoxification treatment for substance use disorders Paola Rosca, Barak Shapira, Yehuda Neumark
98 [GO] 2020―Jul―03 COVID-19 - Enacting a ‘new normal’ for people who use drugs Judy Chang, Jake Agliata, Mauro Guarinieri
99 [GO] 2020―Jul―03 Participation of the nursing workforce to address COVID-19 among people who use alcohol, tobacco, and drugs Vincent Guilamo-Ramos, Adam Benzekri, Marco Thimm-Kaiser, Marissa Abram, Holly Hagan
100 [GO] 2020―Jul―03 Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets Luca Giommoni
101 [GO] 2020―Jul―02 The SARS-Cov-2 threat in Cracolândia, an open-air drug use scene in Brazil Felipe B. Arcadepani, Vitor S. Tardelli, Thiago M. Fidalgo
102 [GO] 2020―Jun―22 An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom Magdalena Harris
103 [GO] 2020―Jun―12 Syringe Services Program (SSP) Operational Changes During the COVID-19 Global Outbreak Tyler S. Bartholomew, Nobuyo Nakamura, Lisa R. Metsch, Hansel E. Tookes
104 [GO] 2020―Jun―11 The Perfect Storm: COVID-19, mass incarceration and the opioid epidemic Trena I. Mukherjee, Nabila El-Bassel
105 [GO] 2020―Jun―03 Challenges of providing COVID-19 prevention services to homeless people who use drugs in Iran Abbas Deilamizade, Amir Moghanibashi-Mansourieh

105 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.017 sec